Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (atsiveria naujas langas)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Šaltinis‎: Br J Haematol 2013;161(5):738-40.

Kodas‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (atsiveria naujas langas)

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. (atsiveria naujas langas)

Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ

Šaltinis‎: Haematologica 2021;106(4):1148-57.

Kodas‎: PubMed 32499239

DOI‎: 10.3324/haematol.2020.251900

https://www.ncbi.nlm.nih.gov/pubmed/32499239 (atsiveria naujas langas)

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia. (atsiveria naujas langas)

Aribi A, Kantarjian H, Koller C, Thomas D, Faderl S, Garcia-Manero G, Cortes J.

Šaltinis‎: Cancer 2008;113(6):1338-43.

Kodas‎: PubMed 18629842

DOI‎: 10.1002/cncr.23718

https://www.ncbi.nlm.nih.gov/pubmed/18629842 (atsiveria naujas langas)

Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia. (atsiveria naujas langas)

Berthelot-Richer M, Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.

Šaltinis‎: Transfusion 2012;52(4):739-41.

Kodas‎: PubMed 22082044

DOI‎: 10.1111/j.1537-2995.2011.03382.x

https://www.ncbi.nlm.nih.gov/pubmed/22082044 (atsiveria naujas langas)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (atsiveria naujas langas)

Bhatia M, Davenport V, Cairo MS.

Šaltinis‎: Leuk Lymphoma 2007;48(1):9-15.

Kodas‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (atsiveria naujas langas)

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide. (atsiveria naujas langas)

Chawla SP, Staddon A, Hendifar A, Messam CA, Patwardhan R, Kamel YM.

Šaltinis‎: BMC Cancer 2013;13:121.

Kodas‎: PubMed 23497336

DOI‎: 10.1186/1471-2407-13-121

https://www.ncbi.nlm.nih.gov/pubmed/23497336 (atsiveria naujas langas)

Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. (atsiveria naujas langas)

Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG.

Šaltinis‎: Pathol Oncol Res 2011;17(1):141-3.

Kodas‎: PubMed 20628840

DOI‎: 10.1007/s12253-010-9276-4

https://www.ncbi.nlm.nih.gov/pubmed/20628840 (atsiveria naujas langas)

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. (atsiveria naujas langas)

Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S.

Šaltinis‎: J Neurooncol 2012;106(2):427-9.

Kodas‎: PubMed 21833801

DOI‎: 10.1007/s11060-011-0675-5

https://www.ncbi.nlm.nih.gov/pubmed/21833801 (atsiveria naujas langas)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (atsiveria naujas langas)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Šaltinis‎: Lancet 2003;361(9354):275-80.

Kodas‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (atsiveria naujas langas)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (atsiveria naujas langas)

Ford PA, Grant SJ, Mick R, Keck G.

Šaltinis‎: J Clin Oncol 2015;33(15):1674-9.

Kodas‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (atsiveria naujas langas)

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. (atsiveria naujas langas)

Gao Y, Liu Q, Shen Y, Li Y, Shao K, Ye B, Shen Y, Zhou Y, Wu D

Šaltinis‎: Platelets. 2022 3;33(7):1024-1030.

Kodas‎: PubMed 35040375

DOI‎: 10.1080/09537104.2022.2026910

https://pubmed.ncbi.nlm.nih.gov/35040375/ (atsiveria naujas langas)

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (atsiveria naujas langas)

Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.

Šaltinis‎: Cancer 2014;120(12):1838-46.

Kodas‎: PubMed 24706489

DOI‎: 10.1002/cncr.28663

https://www.ncbi.nlm.nih.gov/pubmed/24706489 (atsiveria naujas langas)

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. (atsiveria naujas langas)

Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J.

Šaltinis‎: Leuk Lymphoma 2013;54(2):321-8.

Kodas‎: PubMed 22906162

DOI‎: 10.3109/10428194.2012.713477

https://www.ncbi.nlm.nih.gov/pubmed/22906162 (atsiveria naujas langas)

Thrombopoietin-receptor agonists in haematological disorders: the Danish experience. (atsiveria naujas langas)

Gudbrandsdottir S, Frederiksen H, Hasselbalch H.

Šaltinis‎: Platelets 2012;23(6):423-9.

Kodas‎: PubMed 22185370

DOI‎: 10.3109/09537104.2011.634931

https://www.ncbi.nlm.nih.gov/pubmed/22185370 (atsiveria naujas langas)

Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. (atsiveria naujas langas)

Han TT, Xu LP, Liu DH, Liu KY, Wang FR, Wang Y, Yan CH, Chen YH, Sun YQ, Ji Y, Wang JZ, Zhang XH, Huang XJ.

Šaltinis‎: Ann Hematol 2015;94(1):117-28.

Kodas‎: PubMed 25069650

DOI‎: 10.1007/s00277-014-2158-1

https://www.ncbi.nlm.nih.gov/pubmed/25069650 (atsiveria naujas langas)

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma. (atsiveria naujas langas)

Jeong JY, Levine MS, Abayasekara N, Berliner N, Laubach J, Vanasse GJ.

Šaltinis‎: J Hematol Oncol 2015;8:37.

Kodas‎: PubMed 25886818

DOI‎: 10.1186/s13045-015-0136-2

https://www.ncbi.nlm.nih.gov/pubmed/25886818 (atsiveria naujas langas)

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. (atsiveria naujas langas)

Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP.

Šaltinis‎: J Clin Oncol 2010;28(3):437-44.

Kodas‎: PubMed 20008626

DOI‎: 10.1200/JCO.2009.24.7999

https://www.ncbi.nlm.nih.gov/pubmed/20008626 (atsiveria naujas langas)

The use of simple patient blood management strategies as an alternative to platelet and red cell transfusion in autologous stem cell transplant. (atsiveria naujas langas)

Locantore-Ford P, Grant SJ, Keck G.

Šaltinis‎: Blood 2013;122(21):2140.

https://www.bloodjournal.org/content/122/21/2140 (atsiveria naujas langas)

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. (atsiveria naujas langas)

Loo M, Beguin Y.

Šaltinis‎: Blood 1999;93(10):3286-93.

Kodas‎: PubMed 10233880

https://www.ncbi.nlm.nih.gov/pubmed/10233880 (atsiveria naujas langas)

A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia. (atsiveria naujas langas)

Miao J, Leblebjian H, Scullion B, Parnes A

Šaltinis‎: Am J Hematol 2018;93(4):E86-E88.

Kodas‎: PubMed 29274130

DOI‎: 10.1002/ajh.25022

https://www.ncbi.nlm.nih.gov/pubmed/29274130 (atsiveria naujas langas)

Pharmacological therapies to minimise platelet transfusion. (atsiveria naujas langas)

Norfolk DR, Seghatchian J.

Šaltinis‎: Transfus Sci 2000;22(3):149-53.

Kodas‎: PubMed 10831916

https://www.ncbi.nlm.nih.gov/pubmed/10831916 (atsiveria naujas langas)

Romiplostim for management of chemotherapy-induced thrombocytopenia. (atsiveria naujas langas)

Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G.

Šaltinis‎: Support Care Cancer 2014;22(5):1217-22.

Kodas‎: PubMed 24414994

DOI‎: 10.1007/s00520-013-2074-2

https://www.ncbi.nlm.nih.gov/pubmed/24414994 (atsiveria naujas langas)

Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. (atsiveria naujas langas)

Pathak S, Roth M, Verma A, Steidl U.

Šaltinis‎: Expert Opin Drug Metab Toxicol 2013;9(12):1667-75.

Kodas‎: PubMed 24215532

DOI‎: 10.1517/17425255.2013.858119

https://www.ncbi.nlm.nih.gov/pubmed/24215532 (atsiveria naujas langas)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (atsiveria naujas langas)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Šaltinis‎: Leuk Lymphoma. 2019;60(9):2324-7.

Kodas‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (atsiveria naujas langas)

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. (atsiveria naujas langas)

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Šaltinis‎: Lancet Haematol 2015;2(10):e417-26.

Kodas‎: PubMed 26686043

https://www.ncbi.nlm.nih.gov/pubmed/26686043 (atsiveria naujas langas)

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. (atsiveria naujas langas)

Poon LM, Di Stasi A, Popat U, Champlin RE, Ciurea SO.

Šaltinis‎: Am J Blood Res 2013;3(3):260-4.

Kodas‎: PubMed 23997988

https://www.ncbi.nlm.nih.gov/pubmed/23997988 (atsiveria naujas langas)

Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia. (atsiveria naujas langas)

Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Shukla SN.

Šaltinis‎: Indian J Hematol Blood Transfus 2015;31(4):413-5.

Kodas‎: PubMed 26306064

DOI‎: 10.1007/s12288-014-0491-0

https://www.ncbi.nlm.nih.gov/pubmed/26306064 (atsiveria naujas langas)

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. (atsiveria naujas langas)

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Šaltinis‎: Blood 2010;116(12):2127-33.

Kodas‎: PubMed 20530792

DOI‎: 10.1182/blood-2010-03-276691

https://www.ncbi.nlm.nih.gov/pubmed/20530792 (atsiveria naujas langas)

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. (atsiveria naujas langas)

Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U.

Šaltinis‎: Blood 2012;120(2):386-94.

Kodas‎: PubMed 22627766

DOI‎: 10.1182/blood-2011-12-399667

https://www.ncbi.nlm.nih.gov/pubmed/22627766 (atsiveria naujas langas)

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. (atsiveria naujas langas)

Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D.

Šaltinis‎: Cancer 2011;117(5):992-1000.

Kodas‎: PubMed 20945323

DOI‎: 10.1002/cncr.25545

https://www.ncbi.nlm.nih.gov/pubmed/20945323 (atsiveria naujas langas)

Romiplostim treatment of chemotherapy-induced thrombocytopenia. (atsiveria naujas langas)

Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S

Šaltinis‎: J Clin Oncol 2019;37(31):2892-8.

Kodas‎: PubMed 31545663

DOI‎: 10.1200/JCO.18.01931

https://www.ncbi.nlm.nih.gov/pubmed/31545663 (atsiveria naujas langas)

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (atsiveria naujas langas)

Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, Kabrna E, Geissler K, Jilma B.

Šaltinis‎: Blood 2000;95(9):2983-9.

Kodas‎: PubMed 10779449

https://www.ncbi.nlm.nih.gov/pubmed/10779449 (atsiveria naujas langas)

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine. (atsiveria naujas langas)

Svensson T, Chowdhury O, Garelius H, Lorenz F, Saft L, Jacobsen SE, Hellström-Lindberg E, Cherif H.

Šaltinis‎: Eur J Haematol 2014;93(5):439-45.

Kodas‎: PubMed 24853277

DOI‎: 10.1111/ejh.12383

https://www.ncbi.nlm.nih.gov/pubmed/24853277 (atsiveria naujas langas)

Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation. (atsiveria naujas langas)

Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.

Šaltinis‎: Biol Blood Marrow Transplant 2016;22(5):919-24.

Kodas‎: PubMed 26785333

DOI‎: 10.1016/j.bbmt.2016.01.018

https://www.ncbi.nlm.nih.gov/pubmed/26785333 (atsiveria naujas langas)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (atsiveria naujas langas)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Šaltinis‎: Ann Oncol 2005;16(1):139-45.

Kodas‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (atsiveria naujas langas)

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. (atsiveria naujas langas)

Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS.

Šaltinis‎: J Hematol Oncol 2012;5:71.

Kodas‎: PubMed 23190430

DOI‎: 10.1186/1756-8722-5-71

https://www.ncbi.nlm.nih.gov/pubmed/23190430 (atsiveria naujas langas)

Romiplostim for chemotherapy-induced thrombocytopenia: efficacy and safety of extended use. (atsiveria naujas langas)

Wilkins CR, Ortiz J, Gilbert LJ, Yin S, Mones JV, Parameswaran R, Mantha S, Soff GA

Šaltinis‎: Res Pract Thromb Haemost. 2022;6(3):e12701.

Kodas‎: PubMed 35582038

DOI‎: 10.1002/rth2.12701

https://pubmed.ncbi.nlm.nih.gov/35582038/ (atsiveria naujas langas)

Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. (atsiveria naujas langas)

Will B, Kawahara M, Luciano JP, Bruns I, Parekh S, Erickson-Miller CL, Aivado MA, Verma A, Steidl U.

Šaltinis‎: Blood 2009;114(18):3899-908.

Kodas‎: PubMed 19710504

DOI‎: 10.1182/blood-2009-04-219493

https://www.ncbi.nlm.nih.gov/pubmed/19710504 (atsiveria naujas langas)